MALDI mass spectrometry
Accelerate Dx, Bruker Collaborate on Workflow for Postive Blood Culture ID
The companies will validate the use of Accelerate's Arc system for automated positive blood culture sample preparation with Bruker's MALDI Biotyper.
BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System
The next-generation system, which received CE marking last year, identifies bacteria more rapidly and is now commercially available in the US.
Agilent Q3 Revenues Up 6 Percent
The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter.
The company aims to launch a CE-IVD-marked MALDI system in 2021 that will identify bacteria in urinary tract infections without requiring sample culturing.
Biodesix, MRM Proteomics Partner on Lung Cancer Assays
Under the agreement, MRM Proteomics has granted Biodesix rights to use its iMALDI mass spectrometry technologies to develop blood-based tests for lung cancer.
Aug 1, 2018
Jan 25, 2018
Nov 21, 2017